Results 71 to 80 of about 17,963 (297)

Cancer incidence and stage at diagnosis in children and adolescents in the Community of Madrid, 2015–2018

open access: yesPaediatric and Perinatal Epidemiology, EarlyView.
Abstract Background Cancer is the leading cause of death in children aged 1–14 and the second in 15‐19‐year‐old adolescents in Spain. The Paediatric Population‐Based Cancer Registry of the Community of Madrid was created to monitor its incidence and survival.
Raquel López‐González   +5 more
wiley   +1 more source

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

open access: yesClinical Endocrinology, Volume 103, Issue 2, Page 201-208, August 2025.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen   +7 more
wiley   +1 more source

Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study.

open access: yesJournal of Clinical Endocrinology and Metabolism, 2019
CONTEXT Dopamine agonist (DA)-induced impulse control disorder (ICD) in patients with prolactinomas is not sufficiently known. OBJECTIVE To evaluate the prevalence of DA-induced ICDs and possible risk factors related to these disorders in patients with
S. Doğanşen   +14 more
semanticscholar   +1 more source

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. [PDF]

open access: yes, 2019
Background: Pituitary adenomas have a high disease burden due to tumor growth/ invasion and disordered hormonal secretion. Germline mutations in genes such as MEN1 and AIP are associated with early onset of aggressive pituitary adenomas that can be ...
Cano González, David A.   +2 more
core  

The 'incidentaloma' of the pituitary gland. Is neurosurgery required? [PDF]

open access: yes, 1990
We describe a series of 18 patients with an intrasellar mass incidentally discovered by computed tomography or magnetic resonance imaging. The average size of the mass was 13 mm, with a range from 5 to 25 mm.
Allolio, Bruno   +4 more
core   +1 more source

FOXP1-induced lncRNA CLRN1-AS1 acts as a tumor suppressor in pituitary prolactinoma by repressing the autophagy via inactivating Wnt/β-catenin signaling pathway

open access: yesCell Death and Disease, 2019
As the commonest type of functional pituitary tumor, prolactinoma takes up around 40–60% of functional pituitary tumors. Despite dedications attributed to the treatment of prolactinoma, complete cure remains difficult.
Chao Wang   +7 more
semanticscholar   +1 more source

AIP variant causing familial prolactinoma

open access: yesPituitary, 2020
Pathogenic variants in the aryl hydrocarbon receptor-interacting protein ( AIP ) gene are increasingly recognised as a cause of familial isolated pituitary adenoma. AIP -associated tumours are most commonly growth hormone (GH) producing. In our cohort of
D. Carty   +7 more
semanticscholar   +1 more source

Vertebral Metastasis With Syringomyelia Secondary to Breast Adenocarcinoma: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Syringomyelia has several possible causes, commonly including Chiari malformation, spinal cord tumors and injuries, and damage caused by lesions around the spinal cord. A 34‐year‐old female was diagnosed with primary breast cancer and vertebral metastasis and was initiated on an extensive regimen of chemotherapy and radiotherapy.
Ahmed Reda Abdelhalim   +3 more
wiley   +1 more source

Predictors of dopamine agonist resistance in prolactinoma patients

open access: yesBMC Endocrine Disorders, 2020
Background Surgical resection of prolactinomas resistant to dopamine agonists is frequently incomplete due to fibrotic changes of the tumour under pharmacological therapy. In order to identify a subgroup of patients who may benefit from early surgery, we
E. Vermeulen   +6 more
semanticscholar   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

open access: yesClinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Home - About - Disclaimer - Privacy